Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp120: Identification of a very early fusion-independent event as a neutralization target

Journal of General Virology

Volumn 77, Issue 7, 1996, Pages 1397-1402

  Armstrong, S J ^a   Dimmock, N J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION;

EID: 0029990629     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-7-1397     Document Type: Article

References (41)

1. Arendrup, M., Sönnerborg, A., Svennerholm, B., Åkerblom, L., Nielsen, C., Clausen, H., Olofsson, S., Nielsen, J. O. & Hansen, J.-E. S. (1993). Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. Journal of General Virology 74, 855-863.
2. Blumenthal, R., Bali-Puri, A., Walter, A., Covell, D. & Eidelman, O. (1987). pH-dependent fusion of vesicular stomatitis virus with Vero cells. Journal of Biological Chemistry 262, 13614-13619.
3. Boeyé, A., Delaet, I. & Brioen, P. (1994). Antibody neutralization of picornaviruses: can fever help? Trends in Microbiology 2, 255-257.
4. Colonno, R. J., Callahan, P. L., Leippe, D. M., Rueckert, R. R. & Tomassini, J. E. (1989). Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. Journal of Virology 63, 36-42.
5. Cordell, J., Moore, J. P., Dean, C. J., Klasse, P. J., Weiss, R. A. & Mckeating, J. A. (1991). Rat monoclonal antibodies to non-overlapping epitopes of HIV-1 gp120 block CD4-binding in vitro. Virology 185, 72-79.
6. Dietzschold, B., Tollis, M., Lafon, M., Wunner, W. H. & Koprowski, H. (1987). Mechanisms of rabies virus neutralization by glycoprotein specific monoclonal antibodies. Virology 161, 29-36.
7. Dimitrov, D. S., Hillman, K., Manischewitz, J., Blumenthal, R. & Golding, H. (1992). Kinetics of soluble CD4-binding to cell expressing human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology 66, 132-138.
8. Dimmock, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology and Immunology 183, 1-149.
9. Dimmock, N. J. (1995). Update on the neutralisation of animal viruses. Reviews in Medical Virology 5, 165-179.
10. Frey, S., Marsh, M., Gànther, S., Pelchen-Matthews, A., Stephens, P., Ortlepp, S. & Stegmann, T. (1995). Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. Journal of Virology 69, 1462-1472.
11. Gollins, S. & Porterfield, J. S. (1986). A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321, 244-246.
12. Healy, D., Dianda, L., Moore, J. P., McDougal, J. S., Moore, M. J., Estess, P., Buck, D., Kwong, P. D., Beverley, P. C. L. & Sattentau, Q. J. (1990). Novel anti-CD4 monoclonal antibodies separate HIV infection and fusion of CD4+ cells from virus binding. Journal of Experimental Medicine 172, 1233-1242.
13. Ho, D. D., Kaplan, J. C., Rackauskas, I. E. & Gurney, M. E. (1988). Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239, 1021-1023.
14. Iorio, R. M., Glickman, R. L., Riel, A. M., Sheehan, J. P. & Bratt, M. A. (1989). Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent attachment. Virus Research 13, 245-262.
15. Ishada, N. & Ackerman, W. W. (1956). Growth characteristics of influenza virus. Properties of the initial cell-virus complex. Journal of Experimental Medicine 104, 501-505.
16. Kjellén, L. (1985). A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. Journal of General Virology 66, 2279-2283.
17. McDougal, J. S., Nicholson, J. K. A., Cross, G. D., Cort, S. P., Kennedy, M. S. & Mawle, A. C. (1986). Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology 137, 2937-2944.
18. McKeating, J. A. (1992). Neutralization of human immunodeficiency virus. Reviews in Medical Virology, 2, 35-42.
19. McKeating, J. A., Cordell, J. A., Dean, C. J. & Balfe, P. (1992a). Synergistic interaction between ligands binding to the CD4-binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191, 732-742.
20. McKeating, J. A., Thali, M., Furman, C., Karwowska, S., Gorny, M. K., Cordell, J., Zolla-Pazner, S., Sodroski, J. & Weiss, R. A. (1992b). Amino acid residues of the human immunodeficiency virus type 1 gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190, 134-142.
21. McLain, L. & Dimmock, N. J. (1994). Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. Journal of General Virology 75, 1457-1460.
22. Montefiori, D. C., Graham, B. S., Zhou, J., Bucco, R. A., Schwartz, D. M., Cavacini, L. A., Posner, M. R. & NIH-NAIAD Aids Vaccine Clinical Trials Network (1993). V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4-binding site of gp120. Journal of Clinical Investigation 92, 840-847.
23. Moore, J. P. & Ho, D. D. (1993). Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. Journal of Virology 67 863-875.
24. Moore, J. P. & Klasse, P. J. (1992). Thermodynamic and kinetic analysis of sCD4-binding to HIV-1 virions and gp120 dissociation. AIDS Research and Human Retroviruses 8, 443-450.
25. Nara, P. L. (1988). Neutralization of HIV1: a binding/post-binding event mediated through the gp120 immunodominant epitope. In Troisieme Colloque des Cent Gardes, pp. 138-150. Edited by M. Girard & L. Valette. Paris: Pasteur Vaccins.
26. Nara, P. L. (1989). HIV-neutralization: evidence for rapid, binding/ post-binding neutralization from infected humans, chimpanzees and gp120-vaccinated animals. In Vaccines 89: Modern Approaches to New Vaccines including the Prevention of AIDS, pp. 137-144. Edited by R. A. Lerner, H. Ginsberg, R. M. Chanock & F. Brown. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
27. Ohizumi, Y., Suzuki, H., Matsumoto, Y.-I., Mashuo, Y. & Numazaki, Y. (1992). Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55. Journal of General Virology 73, 2705-2707.
28. Osiowy, C. & Anderson, R. (1995). Neutralization of repiratory syncytial virus after cell attachment. Journal of Virology 69, 1271-1274.
29. Outlaw, M. C. & Dimmock, N. J. (1993). IgG-neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway. Virology 195, 413-421.
30. Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H. & Byrn, R. A. (1991). An IgG human monoclonal antibody that reacts with HIV-1/gp120, inhibits virus binding to cells, and neutralizes infection. Journal of Immunology 146, 4325-4332.
31. Rieber, E. P., Federle. C, Reiter, C., Krauss, S., Gürtler, L., Eberle, J., Deinhardt, F. & Riethmüller, G. (1992). The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proceedings of the National Academy of Sciences, USA 89, 10792-10796.
32. Roehrig, J. T., Hunt, A. R., Kinney, R. M. & Mathews, J. H. (1988). In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology 165, 66-73.
33. Russell, P. H. (1984). Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants. Journal of General Virology 65, 795-798.
34. Skinner, M. A., Langlois, A. J., McDanal, C. B., McDougal, J. S., Bolognesi, D. P. & Matthews, T. J. (1988). Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. Journal of Virology 62, 4195-4200.
35. Smith, T. J., Olson, N. H., Cheng, R. H., Liu, H., Chase, E. S., Lee, W. M., Leippe, D. M., Mosser, A. G., Rueckert, R. R. & Baker, T. S. (1993). Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. Journal of Virology, 67, 1148-1158.
36. Sun, N.-C., Ho, D. D., Sun, C. R. Y., Liou, R.-S., Gordon, W., Fung, M. S. C., Li, X.-L., Ting, R. C., Lee, T.-H., Chang, N. T. & Chang, T.-W. (1989). Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. Journal of Virology 63, 3579-3585.
37. Suñé, C., Jiménez, G., Correa, I., Bullido, M. J., Gebauer, F., Smerdou, C. & Enjuanes, L. (1990). Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 177, 559-569.
38. Thali, M., Furman, C., Ho, D. D., Robinson, J. E., Tilley, S. A., Pinter, A. & Sodroski, J. (1992). Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. Journal of Virology 66, 5635-5641.
39. Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J. & Sodroski, J. (1993). Characterization of conserved human immundeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4-binding. Journal of Virology 67, 3978-3988.
40. Vrijsen, R., Mosser, A. & Boeyé, A. (1993). Postadsorbtion neutralization of poliovirus. Journal of Virology 67, 3126-3133.
41. Wohlfart, C. (1988). Neutralization of adenoviruses: kinetics, stoichiometry and mechanisms. Journal of Virology 62, 2321-2328.